1-2 of 2
Kenichi Yoshimura, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

End-of-Treatment 18[F]-FDG PET Can Predict Progression-Free Survival in Patients Undergoing Bendamustine + Rituximab for First Relapsed/Recurrent Follicular Lymphoma: The Result of W- J H S NHL01 Study

Shinya Rai, MD PhD, Koji Kato, MD PhD, Junji Suzumiya, MD PhD, Koji Izutsu, MD PhD, Momoko Nishikori, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD PhD, Kenichi Yoshimura, PhD, Ukihide Tateishi, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tsutomu Takahashi, MD PhD, Takahiro Yamauchi, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5245.
https://doi.org/10.1182/blood-2019-126455
Published: 2019
Journal Articles

Low Serum Total Protein and Unfavorable Pathological Subtype Are Independent Unfavorable Factors in Peripheral T-Cell Lymphoma (PTCL) Treated in Prospective Clinical Tirals; Japan Clinical Oncology Group (JCOG) 0108A Study.

Yoshitoyo Kagami, MD, Tomohiro Kinoshita, MD, Takashi Watanabe, MD, Kuniaki Itoh, MD, Harumi Kaba, MSc, Kenichi Yoshimura, PhD, Motoko Yamaguchi, MD, Mitsutoshi Kurosawa, MD, Kunihiro Tsukasaki, MD, Masaharu Kasai, MD, Kensei Tobinai, MD, Yoshihiro Matsuno, MD, Kiyoshi Mukai, MD, Tomomitsu Hotta, MD, Masanori Shimoyama, MD
Journal: Blood
Blood (2007) 110 (11): 3450.
https://doi.org/10.1182/blood.V110.11.3450.3450
Published: 2007